This rapid COVID test for sale is available to qualified healthcare professionals looking to secure a supply of rapid COVID tests for onsite testing. This rapid test kit will give an easy to read result in about 20 minutes for an active COVID infection. This rapid test kit was also recently approved for a shallow nasal collection, making sample collection much more efficient and comfortable.
This test has not been FDA cleared or approved; the test has been authorized by FDA under an Emergency Use Authorization (EUA) for use by laboratories certified under the CLIA that meet the requirements to perform moderate, high or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
Positive Percent Agreement: 93.1%
Negative Percent Agreement: 98.2%
CPT CODE: 87426
COVID-19 Ag Cards are designed to detect protein antigen from the SARS-CoV-2 virus from nasal specimen samples. Antigen tests can detect the SARS-CoV-2 virus during the active phase of the infection. The collection process is only a couple of steps, and the results are directly onsite in about 20 minutes with no machinery required. Providers can quickly and effectively test large numbers of patients and receive immediate results to help facilitate timely treatment decisions when using a rapid antigen test kit.
Similar to a PCR test, rapid antigen tests can detect the presence of the SARS-CoV-2 virus during the acute stage infection. Although much more efficient in providing timely results, rapid antigen tests can have a lower sensitivity rating when compared to PCR testing, Any negative result on a rapid antigen test should be verified with a PCR test confirmation to appropriately diagnose and treat the case.
Product Discount (Per Box)
Sign up for our newsletter to receive product updates and special offers.